Overview

Analgesic Efficacy of Intravenous Hyoscine-N-Butylbromide (HNB) in Abdominal Colic Associated With Acute Gastroenteritis

Status:
Unknown status

Trial end date:
2016-08-01

Target enrollment:

Participant gender:

Summary

This study aims to assess the analgesic efficacy and safety of intravenous 20 mg Hyoscine-N-Butylbromide versus placebo for the treatment of abdominal colic associated with acute gastroenteritis in the emergency department.

Phase:

Phase 4

Details

Lead Sponsor:

Kocaeli University

Treatments:

Analgesics
Butylscopolammonium Bromide
Scopolamine
Scopolamine Hydrobromide